Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Presentations provide further phase II data on lesinurad in gout

Nov. 9, 2011

Pilot study evaluates apremilast in ankylosing spondylitis

Nov. 8, 2011

Nitazoxanide evaluated in viral respiratory infections

Nov. 8, 2011

Phase III results show immunogenicity of quadrivalent flu vaccine in children

Nov. 8, 2011

Promising data described from several trials of natalizumab in RRMS

Nov. 8, 2011

Shigamabs well tolerated to date in phase II trial

Nov. 7, 2011

Study compares Merck & Co. 15-valent pneumococcal conjugate vaccine to Prevnar

Nov. 7, 2011

Two PentaStaph vaccine components are immunogenic in phase I/II testing

Nov. 7, 2011

Final results available of first OvaSave trial in Crohn's disease

Nov. 7, 2011

Findings reported from REFLEX and MOSAIC trials of IFN-beta1a

Nov. 7, 2011

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...